Ucb Celltech
Records under this name other than patents Ucb Celltech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Ucb Celltech
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,202,405 | Fused Pentacyclic Imidazole Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 7,355,011 | Biological Products Formerly held Term ended Term ended Dec 15, 2024 · High confidence | Term ended | Term ended Dec 15, 2024 | High confidence |
| US 7,186,820 | Production of Humunised Antibodies to Tnf-Alpha Formerly held Term ended Term ended Feb 3, 2022 · High confidence | Term ended | Term ended Feb 3, 2022 | High confidence |
| US RE39,548 | INTERLEUKIN-5 Specific Recombinant Antibodies Term ended Term ended Jun 6, 2015 · Low confidence | Term ended | Term ended Jun 6, 2015 | Low confidence |